DCGI approves specialized center to conduct clinical trials for dermatological products in India

|
Thursday, October 25, 2018
dcgi approves specialized center to conduct clinical trials for dermatological products in india
Image for representation purpose only

New Delhi: In a first, the Drug Controller General of India (DCGI) have given approval to a chain of dermatology and plastic surgery centres— The Esthetic Clinics, for conducting clinical trials and drug development for skin, hair and other plastic surgery medications, cosmetology and cosmetic surgery devices in India.

At present, clinical trials are not mandated for every cosmetic product that enters Indian market provided it is approved in other markets. There are a few clinical trials that are conducted by clinical research organisations in India, but they do not have the clinical acumen in cosmetic, plastic or aesthetic segment. Majority of clinical trial centers work in pharmaceutical drug development, but not for cosmetic and aesthetic solutions.

“Caring for skin and hair is a business where unmet needs still abound and people around the world are waiting for newer and better solutions. Considering India now has the clinical acumen and have the ratification of the DCGI & CDSCO to conduct clinical trials for top quality cosmetic needs, far more newer products and technology will be hitting the Indian market than before. MNCs, as well as homegrown companies, can easily enter the Indian market at much lower costs, keeping in mind local needs”, says Dr Debraj Shome, director, The Esthetic Clinics.

The DCGI under CDSCO is the supreme regulatory authority in India which gives recognition to clinical establishments, hospitals, and organisations based on a set of parameters/guidelines to perform clinical research. These guidelines are aimed to protect patient rights and ensure products fulfill quality standards.

Many products in cosmetology and aesthetics are launched in India based on clinical trials conducted overseas on caucasians or black population and not on the Indian population. "Indian skin is different and therefore it's response to medicines is different. Hence, it becomes important to do clinical trials in our particular population where the product is going to be launched, instead of performing the same in a completely diverse population”, says Dr Rinky Kapoor, director, The Esthetic Clinics.

The Esthetic Clinics has around nine centers across India with 6 centers in Mumbai and one each in Hyderabad, Kolkata, Surat and Delhi.
 

0 Comment

Performing a liver transplant on this three-month-old baby was a deeply gratifying moment in my career 

Surgery has, and continues to fascinate me. I chose a surgical residency due to its immediacy- one can exercise a certain set of skills and be privy to seeing instant resu....

Ophthalmologists can make an early diagnosis of many serious diseases through eye examination: Dr Amod Gupta

 The eye examination is often neglected by primary care physicians. But the fact is eyes act as a diagnostic window, revealing signs of systemic disease before symptoms ap....

This handy, wireless pocket-sized ECG machine can revolutionise cardiac care 

This engineer couple, Neha and Rahul, took up the challenge to make a leadless, portable ECG device themselves....

University of Dundee Research aims to solve Neuropathic Pain mysteries

Researchers at the University of Dundee seek to understand the mechanisms driving neuropathic pain and its intensity in patients, which affects appr....

 

The Research International Conference on Medical, Medicine and Health Science will be held in New Delhi, India on March 25, 2024....